Trial intelligence / Profile preview

Baclofen for Acute Alcohol Withdrawal

NCT03293017Phase 4Unknown

Sponsor
UZ Brussel
Start
Feb 2016
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of baclofen in alcohol withdrawal syndrome (AWS), sponsored by UZ Brussel. Status: unknown.

02

Drugs

baclofen
03

Conditions

alcohol withdrawal syndrome (AWS)

Beyond the preview

Go deeper on NCT03293017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03293017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call